| 3/15/2021 |
Dr Song's 3D Urology and Prostate Clinics Bring 3D Targeted Treatment To Treat Various Prostate and Genitourinary Inflammations |
mysorenewspaper.com |
... formula eliminates all pathogens and pathogenic factors, releases toxic substances, and effectively treats various severe urogenital inflammation and prostate diseases. Targeted natural extracts have no problems in the body and no drug resistance. 3D Precision Medicine Technology Co, Ltd is a widely known company that works with top leading institutes like the Chinese medicine research institute and modern biotechnology companies to deeply learn about natural-source targeted extracts. This extract ... |
| 3/15/2021 |
Dr Song's 3D Urology and Prostate Clinics Bring 3D Targeted Treatment To Treat Various Prostate and Genitourinary Inflammations |
ussharemarkets.com |
... formula eliminates all pathogens and pathogenic factors, releases toxic substances, and effectively treats various severe urogenital inflammation and prostate diseases. Targeted natural extracts have no problems in the body and no drug resistance. 3D Precision Medicine Technology Co, Ltd is a widely known company that works with top leading institutes like the Chinese medicine research institute and modern biotechnology companies to deeply learn about natural-source targeted extracts. This extract ... |
| 3/15/2021 |
Dr Song's 3D Urology and Prostate Clinics Bring 3D Targeted Treatment To Treat Various Prostate and Genitourinary Inflammations |
nationalnewsmagazine.com |
... formula eliminates all pathogens and pathogenic factors, releases toxic substances, and effectively treats various severe urogenital inflammation and prostate diseases. Targeted natural extracts have no problems in the body and no drug resistance. 3D Precision Medicine Technology Co, Ltd is a widely known company that works with top leading institutes like the Chinese medicine research institute and modern biotechnology companies to deeply learn about natural-source targeted extracts. This extract ... |
| 3/11/2021 |
Why Genetic Screening Represents A New Frontier For Precision Medicine |
Forbes |
... health diagnoses and treatment strategies are not tailored to individual needs. Instead, healthcare providers largely rely on outdated systems of tracking, classification and prediction to screen individuals for risks of adverse outcomes.Filling The Precision Medicine Technology GapIn recent years, genetic or DNA testing products have emerged in healthcare settings. These products help diagnose or rule out suspected genetic disorders to predict risks for specific conditions or to acquire ... |
| 3/10/2021 |
My interviews with Sirj Goswami and Steeve Huin |
dotmed.com |
... the coronavirus pandemic.Over the last week I have had the pleasure of speaking to Sirj Goswami and Steeve Huin.In the following installment, I check in with Sirj Goswami, CEO of InsightRX, a precision medicine technology company that focuses on ensuring drug doses are appropriate for the individuals receiving them. 293349Times Visited: 2360 Servicing GE, Philips and Siemens CT equipment with OEM trained engineers Numed, a well established ... |
| 3/9/2021 |
Five Minutes in Healthcare - featuring Sirj Goswami |
dotmed.com |
... the industry's most influential leaders, as well as innovative thinkers who are working to meet the challenges of the novel coronavirus.In this installment, I check in with Sirj Goswami, CEO of InsightRX, a precision medicine technology company that focuses on ensuring drug doses are appropriate for the individuals receiving them.We hope you enjoy the conversation. Please tell us what you think, and let us know who you would ... |
| 10/13/2020 |
Alarming Increase in Cancer Fatalities Looms Unless Cancer Screenings Resume |
PRWeb |
... on the surface of cancer cells. When paired with imaging methods, this test will facilitate physicians with a more precise diagnosis tool which additionally allows targeted therapy delivery. The Cancer Consortium recently called NuView’s precision medicine technology a “breakthrough…uniquely positioned to confirm cancer” on the cell surface with greater than 95% sensitivity. (6) “Don’t let fear stop you from taking care of yourself. Cancer screenings are an important tool ... |
| 8/25/2020 |
Park City company develops new ground breaking cancer treatment |
utahbusiness.com |
... and PACAP overexpressed on the surface of cancer cells. Combined with medical imaging methods, NuView’s test provides physicians a more precise diagnosis and allows for targeted therapy delivery. The Cancer Consortium recently called NuView’s precision medicine technology a “breakthrough…uniquely positioned to confirm cancer” on the cell surface with greater than 95 percent sensitivity. (1) NuView seeks to help patients avoid surgical biopsy For patients, theranostics diagnostics avoids painful surgical ... |
| 7/29/2020 |
Trobix Bio completed Series A funding by a leading Japanese/Singapore fund |
PR Newswire |
... range of bacterial pathogens, and actively sensitize these pathogens to antibiotics. The company's lead product, TBX101, aims to treat patients carrying gut antimicrobial resistant bacteria, resulting in an antibiotic sensitive gut microbiome. Trobix Bio's precision medicine technology minimizes resistance development to TBX101. About Chartered Opus Chartered Opus is a production platform for investment products combining structural and technological innovations to a new methodology in Structured Products. Opus is the preferred ... |
| 6/30/2020 |
PROTXX and University of Alberta Announce Remote Personalized Healthcare Collaboration for Patients with Multiple Sclerosis |
BioSpace |
PROTXX and University of Alberta Announce Remote Personalized Healthcare Collaboration for Patients with Multiple Sclerosis Published: Jun 30, 2020 MENLO PARK , Calif. and EDMONTON, Alberta , June 30, 2020 /PRNewswire/ -- Silicon Valley, California and Calgary, Alberta based precision medicine technology pioneer PROTXX and the University of Alberta in Edmonton, Alberta today announced a new research collaboration that will leverage the PROTXX precision healthcare platform for remote personalized health management of patients ... |
| 6/10/2020 |
PROTXX and AltaML form wearable device and machine learning alliance |
medicaldevice-network.com |
PROTXX and AltaML form wearable device and machine learning alliance Share ajohney 3 hours ago Precision medicine technology company PROTXX and artificial intelligence (AI) and machine learning (ML) product developer AltaML have partnered to augment the data analytics capabilities of the PROTXX precision healthcare platform. The collaboration aims to enable PROTXX platform to support automated diagnoses of neurodegenerative medical conditions. The platform is designed to replace expensive clinical equipment and ... |
| 6/9/2020 |
PROTXX and AltaML Announce Wearable Device and Machine Learning Collaboration |
Benzinga |
MENLO PARK, Calif. and EDMONTON, Alberta , June 9, 2020 /CNW/ -- Silicon Valley- and Calgary -based precision medicine technology pioneer PROTXX and Alberta -based artificial intelligence (AI) and machine learning (ML) product developer AltaML today announced that they have launched a collaboration to expand the data analytics capabilities of the PROTXX precision healthcare platform to support automated diagnoses of neurodegenerative medical conditions. The PROTXX precision healthcare platform integrates wearable sensor and ... |
| 6/9/2020 |
PROTXX and AltaML Announce Wearable Device and Machine Learning Collaboration |
Benzinga |
MENLO PARK, Calif. and EDMONTON, Alberta , June 9, 2020 /PRNewswire/ -- Silicon Valley- and Calgary -based precision medicine technology pioneer PROTXX and Alberta -based artificial intelligence (AI) and machine learning (ML) product developer AltaML today announced that they have launched a collaboration to expand the data analytics capabilities of the PROTXX precision healthcare platform to support automated diagnoses of neurodegenerative medical conditions. The PROTXX precision healthcare platform integrates wearable sensor and ... |
| 6/9/2020 |
PROTXX and AltaML Announce Wearable Device and Machine Learning Collaboration |
PR Newswire |
PROTXX logo (PRNewsfoto/PROTXX, Inc.) AltaML logo MENLO PARK, Calif. and EDMONTON, Alberta Silicon Valley- and Calgary -based precision medicine technology pioneer PROTXX and Alberta -based artificial intelligence (AI) and machine learning (ML) product developer AltaML today announced that they have launched a collaboration to expand the data analytics capabilities of the PROTXX precision healthcare platform to support automated diagnoses of neurodegenerative medical conditions. The PROTXX precision healthcare platform integrates ... |
| 5/28/2020 |
Precision Medicine Tech Company ‘Syapse’ Announces $30 Million Funding |
aithority.com |
... making medicine and the science of applying it to the right cause. In technical parlance, we can call Precision Medicine as “programmatic” clinical drug management, like we have programmatically-controlled advertising. Syapse, a leading Precision medicine technology company, has been working closely with the oncologists and drug companies to develop ‘real-world evidence in oncology.’ Today, Syapse has announced $30 million in new equity funding to accelerate the creation and ... |
| 4/2/2020 |
Precision Medicine Technology Advancements and Business Outlook 2020 | Johnson & Johnson, IBM, GE Healthcare |
BioSpace |
New York City, NY: April 02, 2020 – Published via (Wired Release) – The Exclusive Research Report on Precision Medicine with Industry-Primary Research, Secondary Research, Product Research, Revenue, Emerging Trends and Top Growing Companies 2020-2029″. The report points that are discussed within the systematic approach are the major market players that are involved in the precision medicine such as manufacturers , raw material suppliers, equipment suppliers, end users, traders, distributors and etc ... |
| 11/18/2019 |
Analytics, precision medicine key to value-based care, but health systems struggle with funding: KLAS survey |
FierceHealthcare |
... there is tremendous optimism in the potential of precision medicine. However, reimbursement and generating a return on investment are significant challenges, CIOs surveyed said. Barriers to entry are high, and, so far, adoption of precision medicine technology is currently limited to relatively few organizations—only 12% of interviewed health systems, mostly larger organizations, can be categorized as mature in their precision medicine efforts, the report said. On average, those organizations ... |
| 10/8/2019 |
Bioinformatics Analyst I |
omniseq.com |
Bioinformatics Analyst I Job Description OmniSeq is focused on delivering patients with cancer better access to the power of precision medicine technology and new hope for better outcomes. We provide oncology groups, hospitals and healthcare systems with the first-ever fusion of clinical genomics and a comprehensive information technology solution with easy access to actionable insights about their patient’s condition and available treatment options. OmniSeq currently offers to the commercial ... |
| 9/11/2019 |
Implementation best practices: The best approaches to precision medicine |
Healthcare IT News |
Four precision medicine experts – a groundbreaking provider organization and three precision medicine technology vendors – offer healthcare CIOs and other leaders their expertise for getting started with the nascent area of medicine. Implementation best practices: The best approaches to precision medicine September 11, 2019 12:38 PM Precision medicine is just starting to gain ground in the healthcare industry. Most patients have yet to have medical care designed to enhance effectiveness or ... |
| 9/5/2019 |
University partners with AI company to further medical research |
dailyillini.com |
... treatment that takes into account variations in people’s genes, environment and lifestyle. The University will gain access to all of the AI problems Infosys is trying to solve. In order to implement AI into precision medicine technology , any and all errors must be figured out beforehand. University researchers and students will be taking these problems and implementing them in their research. In turn, once the problems with the AI are ... |